These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 25975912)
1. [Epidermal growth factor-like domain 7 promotes endothelial cell migration and angiogenesis by activating ERK signaling pathway]. Cao Y; Lyu Q Zhonghua Bing Li Xue Za Zhi; 2015 Apr; 44(4):270-3. PubMed ID: 25975912 [TBL] [Abstract][Full Text] [Related]
2. EGFL7 is expressed in bone microenvironment and promotes angiogenesis via ERK, STAT3, and integrin signaling cascades. Chim SM; Kuek V; Chow ST; Lim BS; Tickner J; Zhao J; Chung R; Su YW; Zhang G; Erber W; Xian CJ; Rosen V; Xu J J Cell Physiol; 2015 Jan; 230(1):82-94. PubMed ID: 24909139 [TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor-like domain 7 promotes migration and invasion of human trophoblast cells through activation of MAPK, PI3K and NOTCH signaling pathways. Massimiani M; Vecchione L; Piccirilli D; Spitalieri P; Amati F; Salvi S; Ferrazzani S; Stuhlmann H; Campagnolo L Mol Hum Reprod; 2015 May; 21(5):435-51. PubMed ID: 25667199 [TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor-like domain 7 regulates breast cancer cell proliferation and vascular endothelial growth factor expression via the p38MAPK signaling pathway. Zhou B; Wang J Am J Transl Res; 2021; 13(4):2608-2616. PubMed ID: 34017420 [TBL] [Abstract][Full Text] [Related]
5. Role of EGFL7/EGFR-signaling pathway in migration and invasion of growth hormone-producing pituitary adenomas. Liu Q; Zhang J; Gao H; Yuan T; Kang J; Jin L; Gui S; Zhang Y Sci China Life Sci; 2018 Aug; 61(8):893-901. PubMed ID: 29951953 [TBL] [Abstract][Full Text] [Related]
6. In-vitro inhibitory effect of EGFL7-RNAi on endothelial angiogenesis in glioma. Li Q; Wang AY; Xu QG; Liu DY; Xu PX; Yu D Int J Clin Exp Pathol; 2015; 8(10):12234-42. PubMed ID: 26722408 [TBL] [Abstract][Full Text] [Related]
7. Effects of microRNA-126 on cell proliferation, apoptosis and tumor angiogenesis via the down-regulating ERK signaling pathway by targeting EGFL7 in hepatocellular carcinoma. Gong C; Fang J; Li G; Liu HH; Liu ZS Oncotarget; 2017 Aug; 8(32):52527-52542. PubMed ID: 28881749 [TBL] [Abstract][Full Text] [Related]
8. EGFL7: Master regulator of cancer pathogenesis, angiogenesis and an emerging mediator of bone homeostasis. Hong G; Kuek V; Shi J; Zhou L; Han X; He W; Tickner J; Qiu H; Wei Q; Xu J J Cell Physiol; 2018 Nov; 233(11):8526-8537. PubMed ID: 29923200 [TBL] [Abstract][Full Text] [Related]
9. EGF-like-domain-7 is required for VEGF-induced Akt/ERK activation and vascular tube formation in an ex vivo angiogenesis assay. Takeuchi K; Yanai R; Kumase F; Morizane Y; Suzuki J; Kayama M; Brodowska K; Nakazawa M; Miller JW; Connor KM; Vavvas DG PLoS One; 2014; 9(3):e91849. PubMed ID: 24647208 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of EGFL7 promotes angiogenesis and nerve regeneration in peripheral nerve injury. Hao Z; Huo Z; Aixin-Jueluo Q; Wu T; Chen Y Cell Biol Int; 2024 Nov; 48(11):1698-1713. PubMed ID: 39080995 [TBL] [Abstract][Full Text] [Related]
11. VE-statin/Egfl7 siRNA inhibits angiogenesis in malignant glioma in vitro. Huang C; Yuan X; Li Z; Tian Z; Zhan X; Zhang J; Li X Int J Clin Exp Pathol; 2014; 7(3):1077-84. PubMed ID: 24696724 [TBL] [Abstract][Full Text] [Related]
12. EGFL6 promotes endothelial cell migration and angiogenesis through the activation of extracellular signal-regulated kinase. Chim SM; Qin A; Tickner J; Pavlos N; Davey T; Wang H; Guo Y; Zheng MH; Xu J J Biol Chem; 2011 Jun; 286(25):22035-46. PubMed ID: 21531721 [TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor-like domain 7 promotes cell invasion and angiogenesis in pancreatic carcinoma. Shen X; Han Y; Xue X; Li W; Guo X; Li P; Wang Y; Li D; Zhou J; Zhi Q Biomed Pharmacother; 2016 Feb; 77():167-75. PubMed ID: 26796281 [TBL] [Abstract][Full Text] [Related]
14. Decreased expression of the endothelial cell-derived factor EGFL7 in systemic sclerosis: potential contribution to impaired angiogenesis and vasculogenesis. Manetti M; Guiducci S; Romano E; Avouac J; Rosa I; Ruiz B; Lepri G; Bellando-Randone S; Ibba-Manneschi L; Allanore Y; Matucci-Cerinic M Arthritis Res Ther; 2013 Oct; 15(5):R165. PubMed ID: 24286167 [TBL] [Abstract][Full Text] [Related]
15. New proangiogenic activity on vascular endothelial cells for C-terminal mechano growth factor. Deng M; Wang Y; Zhang B; Liu P; Xiao H; Zhao J Acta Biochim Biophys Sin (Shanghai); 2012 Apr; 44(4):316-22. PubMed ID: 22382131 [TBL] [Abstract][Full Text] [Related]
16. EGFL7 Mediates BMP9-Induced Sprouting Angiogenesis of Endothelial Cells Derived from Human Embryonic Stem Cells. Richter A; Alexdottir MS; Magnus SH; Richter TR; Morikawa M; Zwijsen A; Valdimarsdottir G Stem Cell Reports; 2019 Jun; 12(6):1250-1259. PubMed ID: 31155507 [TBL] [Abstract][Full Text] [Related]
17. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis. Lovren F; Pan Y; Shukla PC; Quan A; Teoh H; Szmitko PE; Peterson MD; Gupta M; Al-Omran M; Verma S Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1440-9. PubMed ID: 19351806 [TBL] [Abstract][Full Text] [Related]
18. Glial cell-induced endothelial morphogenesis is inhibited by interfering with extracellular signal-regulated kinase signaling. Chandrasekar N; Mohanam S; Lakka SS; Dinh DH; Olivero WC; Gujrati M; Rao JS Clin Cancer Res; 2003 Jun; 9(6):2342-9. PubMed ID: 12796404 [TBL] [Abstract][Full Text] [Related]
19. EGFL7 is a chemoattractant for endothelial cells and is up-regulated in angiogenesis and arterial injury. Campagnolo L; Leahy A; Chitnis S; Koschnick S; Fitch MJ; Fallon JT; Loskutoff D; Taubman MB; Stuhlmann H Am J Pathol; 2005 Jul; 167(1):275-84. PubMed ID: 15972971 [TBL] [Abstract][Full Text] [Related]